おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hangzhou Just Biotherapeutics (Just China)
company
About
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Close
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company dedicated to accelerating the development of bio-medicine and significantly reducing manufacturing costs. Their core strengths are molecular design, process design, drug product design and manufacturing plant design.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$64M ¥400M
Hangzhou Just Biotherapeutics (Just China) has raised a total of
$64M ¥400M
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2018 | Series B | $35M | 3 | — | — | Detail |
| Aug 8, 2017 | Series B | ¥400M | 2 | — | — | Detail |
| Jul 25, 2016 | Series A | $14M | 3 | — | — | Detail |
| Sep 21, 2015 | Series A | $15M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Hangzhou Just Biotherapeutics (Just China) is funded by 4 investors.
ARCH Venture Partners
and BOCGI Zheshang Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
BOCGI Zheshang Capital
|
— | Series B |
Lilly Asia Ventures
|
— | Series B |
Merck
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
